BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23390219)

  • 1. Borderline lepromatous leprosy in an Italian man.
    Massone C; Clapasson A; Nunzi E
    Am J Trop Med Hyg; 2013 Feb; 88(2):211. PubMed ID: 23390219
    [No Abstract]   [Full Text] [Related]  

  • 2. Borderline Lepromatous Leprosy with Type 1 (Reversal) Reactions in a Chinese Man.
    Fu X; Liu H; Zhang F
    Am J Trop Med Hyg; 2015 Aug; 93(2):207-209. PubMed ID: 26251526
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of Hansen Disease presenting as tinea versicolor.
    Yang S; Makredes M; O'Donnell P; Levin NA
    Dermatol Online J; 2013 Apr; 19(4):7. PubMed ID: 24021367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Borderline lepromatous leprosy].
    El Morabite K; Tbatou F; Ait Ourhroui M; Senouci K; Hassam B
    Presse Med; 2014 Jun; 43(6 Pt 1):733-4. PubMed ID: 24703733
    [No Abstract]   [Full Text] [Related]  

  • 5. Borderline Lepromatous Leprosy: Cutaneous Manifestation and Type 1 Reversal Reaction.
    Hattori M; Motegi S; Amano H; Ishii N; Ishikawa O
    Acta Derm Venereol; 2016 Mar; 96(3):422-3. PubMed ID: 26439279
    [No Abstract]   [Full Text] [Related]  

  • 6. Leprosy pseudoimbricata: an unusual presentation of steroid-modified borderline lepromatous leprosy.
    Kumar S; Mehta H; Aggarwal D; Chatterjee D; Narang T; Dogra S
    Int J Dermatol; 2020 Apr; 59(4):e124-e125. PubMed ID: 31957882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Polyarthritis and papular eruption revealing leprosy].
    Meyer M; Ingen-Housz-Oro S; Ighilahriz O; Wendling J; Gaulier A; Levy-Weil F; Sigal-Grinberg M; Flageul B
    Rev Med Interne; 2008 Mar; 29(3):242-5. PubMed ID: 17976874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythema nodosum leprosum presenting as sweet's syndrome-like reaction in a borderline lepromatous leprosy patient.
    Suryawati N; Saputra H
    Int J Mycobacteriol; 2018; 7(2):191-194. PubMed ID: 29900900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two microbiological relapses in a patient with lepromatous leprosy.
    Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
    Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacillaemia in leprosy and effect of multidrug therapy.
    Chatterjee G; Kaur S; Sharma VK; Vaishnavi C; Ganguly NK
    Lepr Rev; 1989 Sep; 60(3):197-201. PubMed ID: 2682105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and bacteriological progress of highly bacillated BL-LL patients discontinuing treatment after different periods of MDT.
    Katoch K; Natarajan M; Bagga A; Katoch VM
    Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):248-54. PubMed ID: 2071982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of minocycline in single dose and at 100 mg twice daily for lepromatous leprosy.
    Gelber RH; Murray LP; Siu P; Tsang M; Rea TH
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):568-73. PubMed ID: 7868955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycobacteria in nerve trunks of long-term treated leprosy patients.
    Pereira JH; Palande DD; Gschmeissner SE
    Lepr Rev; 1991 Jun; 62(2):134-42. PubMed ID: 1870375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The response to chemotherapy of serum Mycobacterium leprae-specific antigen in multibacillary leprosy patients.
    Roche PW; Britton WJ; Neupane KD; Failbus SS; Cho SN; Theuvenet WJ
    Am J Trop Med Hyg; 1991 Jun; 44(6):702-8. PubMed ID: 1858971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leprosy. Recognition and treatment.
    Ramos-e-Silva M; Rebello PF
    Am J Clin Dermatol; 2001; 2(4):203-11. PubMed ID: 11705247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline lepromatous leprosy masking as tinea versicolor.
    Day W; Prodanovic E
    Int J Dermatol; 2019 Jun; 58(6):e125-e126. PubMed ID: 30891732
    [No Abstract]   [Full Text] [Related]  

  • 17. Resolution of lepromatous leprosy after a short course of amoxicillin/clavulanic acid, followed by ofloxacin and clofazimine.
    Villahermosa LG; Walsh DS; Fajardo TT; Abalos RM; dela Cruz EC; Veerasubramanian P; Walsh GP
    Int J Dermatol; 1999 Jul; 38(7):558-60. PubMed ID: 10440294
    [No Abstract]   [Full Text] [Related]  

  • 18. Histopathologic observations on the persistence of Mycobacterium leprae in the skin of multibacillary leprosy patients under chemotherapy.
    Wabitsch KR; Meyers WM
    Lepr Rev; 1988 Dec; 59(4):341-6. PubMed ID: 2468983
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of a modified WHO regimen in highly bacilliferous BL/LL patients.
    Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa ; Sharma VD; Shivannavar CT; Katoch VM
    Int J Lepr Other Mycobact Dis; 1989 Jun; 57(2):451-7. PubMed ID: 2664042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Borderline lepromatous leprosy presenting as a single cutaneous plaque.
    Armour KS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2005 Aug; 46(3):181-3. PubMed ID: 16008652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.